Evidence map›Paper›PMID 33369444›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.

Abbasali Hosein Pour Feizi, Sirous Zeinali, Jacek Toporski, Roghayeh Sheervalilou, Sahar Mehranfar

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Cancers · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Abbasali Hosein Pour FeiziHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sirous ZeinaliDepartment of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Jacek ToporskiDepartment of Clinical Sciences, Pediatric Oncology and Hematology, University of Lund, Lund, Sweden.
Roghayeh SheervalilouPharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Sahar MehranfarHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Kowsar Hospital · IRLund University · SETabriz University of Medical Sciences · IRUrmia University · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIt was shown by genomic profiling that despite no detectable chromosomal abnormalities a proportion of children with pre-B acute lymphoblastic leukemia harbors copy number alterations (CNA) of genes playing role in B-cell development and function. The aim of the study was to determine the frequency of CNA in pediatric acute lymphoblastic leukemia and correlate these findings with clinical outcome.

methodsDNA extracted from peripheral blood or bone marrow at diagnosis/relapse of fifty newly diagnosed children with precursor B-cell acute lymphoblastic leukemia was analyzed for CNA with multiplex ligation-dependent probe amplification.

resultsThe analysis revealed 76 CNA in 24 patients most frequently found in PAR1 (17%), CDKN2A/B (15.7%) and PAX5 (14.4%) genes. There were significant CNA co-occurrences between PAX5, CDKN2A/B, BTG1, ETV6, PAR1 or XP22 genes, (p <0.020) and the high-risk group. There was a significant correlation between EBF1, RB1, and IKZF1 alterations and bone marrow relapse. Patients with CNA in screened genes are more likely to succumb to their disease except for those with PAR1 or XP22 genes (p <0.050).

conclusionThe multiplex ligation-dependent probe amplification could be considered as an independent diagnostic tool allowing prompt identification of patients at high risk of treatment failure and, subsequently, a more adequate treatment approach.

Indexed as

Chromosome AberrationsDNA Copy Number VariationsGene DeletionAdolescentBiomarkers, TumorChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantMaleMultiplex Polymerase Chain ReactionPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrognosisBiomarkers, TumorCDKN2A/BChildhood acute lymphoblastic leukemia (ALL)copy number alterations (CNA)multiplex ligation-dependent probe amplification (MLPA)PAX5

Identifiers

PMID33369444
PMCPMC8046302
OpenAlexW3116066220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.